Home/Investors/SR One

SR One

Biotech Investor · 4 portfolio companies

Portfolio

4

Focus Areas

10

Top Stage

Phase 2

Investment Focus

Pulmonary Fibrosis Interstitial Lung Diseases Rare Respiratory Diseases Alzheimer's Disease Parkinson's Disease Orphan Tauopathies Neurodegenerative Disorders Neuropsychiatry Major Depressive Disorder Ophthalmology

Portfolio Companies

Company	Stage	Valuation	Focus
Avalyn Pharmaceuticals	Phase 2	—	Pulmonary Fibrosis, Interstitial Lung Diseases
Asceneuron	Pre-clinical	—	Alzheimer's Disease, Parkinson's Disease
Draig Therapeutics	Phase 2	—	Neuropsychiatry, Major Depressive Disorder
Surrozen	—	—	Ophthalmology

Frequent Co-Investors

The Column Group1 shared Johnson & Johnson Innovation – JJDC1 shared F-Prime Capital1 shared Suvretta Capital Management1 shared Sofinnova Partners1 shared Sanofi Ventures1 shared Norwest Venture Partners1 shared Novo Ventures1 shared